Parkinson Disease Patient with Wheezing Manifestations: A Case Report

Source:
By:Mimi Zhou, Siyuan Jing, Yue Chen

DOI: https://doi.org/10.30564/jgm.v3i1.2934

Abstract:

The dosing of anti-Parkinson drugs is considered as the optimal control of the symptoms of PD, and increasing the dose of drugs is a common method to treat the aggravate state of PD. However, this is a case of PD elderly patient who had nephritic syndrome, with an increase in the dose, the symptoms did not get improved, but a series of other adverse effects appeared.

References:

[1]Silvia A Mandel, Only Weinreb, Tamar Amit, et al (2005) Mechanism of neuroprotective action of the anti-Parkinson drug rasagiline and its derivatives. Brain Research Reviews 48: 379-87. [2]Wichmann T, DeLong MR (2003) Functional neuroanatomy of the basal ganglia in Parkinson’s disease. Adv Neurol 91: 9-18. [3]Brotchie JM, Lee J, and Venderova K (2005) Levodopa-induced dyskinesia in Parkinson’s disease. J Neural Transm 112: 359-91. [4] Torsney KM, Forsyth D (2017) Breathing problems in Parkinson's disease: a common problem, rarely diagnosed. Atlas of Science another view on science http://atlasofscience.org